Page 129 - MI-1-1

Microbes & Immunity Re-emergence of M. pneumoniae in the post-COVID-19 era

close collaborations between governments, health [Last accessed on 2023 Dec 13].
authorities, clinical microbiologists, and infectious disease 8. Bolluyt DC, Euser SM, Souverein D, et al. Increased
specialists are required to improve the diagnostic capacity, incidence of Mycoplasma pneumoniae infections and
along with the development of AST-guided antibiotic hospital admissions in the Netherlands, November to
therapy for M. pneumoniae infections, particularly for December 2023. Euro Surveill. 2024;29(4):2300724.
pediatric cases. Finally, it is essential for clinicians to doi: 10.2807/1560-7917.ES.2024.29.4.2300724
recognize the clinical significance of M. pneumoniae as a
respiratory pathogen and to familiarize themselves with 9. Nordholm AC, Soborg B, Jokelainen P, et al. Mycoplasma
other agents that are potentially associated with atypical pneumoniae epidemic in Denmark, October to December,
pneumonia, including Chlamydia pneumoniae, Chlamydia 2023. Euro Surveill. 2024;29(2):2300707.
psittaci, and Legionella pneumophila. doi: 10.2807/1560-7917.ES.2024.29.2.2300707

Conflict of interest 10. Larcher R, Boudet A, Roger C, Villa F, Loubet P. Mycoplasma
pneumoniae is back! Is it the next pandemic? Anaesth Crit
The author declares that he has no competing interests. Care Pain Med. 2023;43(1):101338.
doi: 10.1016/j.accpm.2023.101338
References
11. Edens C, Clopper BR, DeVies J, et al. Notes from the field:
1. Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, Reemergence of Mycoplasma pneumoniae infections in
van Rossum AM. Infection with and carriage of Mycoplasma children and adolescents after the COVID-19 pandemic,
pneumoniae in children. Front Microbiol. 2016;7:329. United States, 2018-2024. MMWR Morb Mortal Wkly
doi: 10.3389/fmicb.2016.00329 Rep. 2024;73(7):149-151.
2. Meyer Sauteur PM, Beeton ML, Uldum SA, et al. Mycoplasma doi: 10.15585/mmwr.mm7307a3
pneumoniae detections before and during the COVID-19 12. Ministry of Health, Indonesia. Mycoplasma pneumoniae
pandemic: Results of a global survey, 2017 to 2021. Euro Ditemukan di Indonesia (Mycoplasma pneumoniae is Found
Surveill. 2022;27(19):2100746. in Indonesia); 2023 Available from: https://sehatnegeriku.
doi: 10.2807/1560-7917.ES.2022.27.19.2100746 kemkes.go.id/baca/umum/20231206/1044400/
mycoplasma-pneumoniae-ditemukan-di-indonesia [Last
3. Meyer Sauteur PM, Chalker VJ, Berger C, Nir-Paz R, accessed on 2023 Dec 13].
Beeton ML, ESGMAC and the ESGMAC-MyCOVID Study
Group. Mycoplasma pneumoniae beyond the COVID-19 13. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical
pandemic: Where is it? Lancet Microbe. 2022;3(12):e897. manifestations, pathogenesis and laboratory detection of
Mycoplasma pneumoniae infections. FEMS Microbiol Rev.
doi: 10.1016/S2666-5247(22)00190-2
2008;32(6):956-973.
4. Meyer Sauteur PM, Beeton ML, ESGMAC the ESGMAC doi: 10.1111/j.1574-6976.2008.00129.x
MAPS Study Group. Mycoplasma pneumoniae: Gone
forever? Lancet Microbe. 2023;4(10):e763. 14. Sreenath K, Kabra SK, Dey AB, et al. Mycoplasma
pneumoniae among hospitalized patients with acute
doi: 10.1016/S2666-5247(23)00182-9
respiratory tract infections in an Indian tertiary care
5. Barnes M, Youngkin E, Zipprich J, et al. Notes from the hospital: An underreported health problem. Microbiol
field: Increase in pediatric invasive Group A Streptococcus Spectr. 2022;10(4):e0158922.
infections - Colorado and Minnesota, October-December
2022. MMWR Morb Mortal Wkly Rep. 2023;72(10):265-267. doi: 10.1128/spectrum.01589-22
15. Suzuki Y, Itagaki T, Seto J, et al. Community outbreak of
doi: 10.15585/mmwr.mm7210a4
macrolide-resistant Mycoplasma pneumoniae in Yamagata,
6. Meyer Sauteur PM, Beeton ML, European Society of Japan in 2009. Pediatr Infect Dis J. 2013;32(3):237-240.
Clinical Microbiology and Infectious Diseases (ESCMID) doi: 10.1097/INF.0b013e31827aa7bd
Study Group for Mycoplasma and Chlamydia Infections
(ESGMAC), and the ESGMAC Mycoplasma pneumoniae 16. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for
Surveillance (MAPS) Study Group. Mycoplasma community-acquired lower respiratory tract infections
pneumoniae: Delayed re-emergence after COVID-19 secondary to Mycoplasma pneumoniae in children. Cochrane
pandemic restrictions. Lancet Microbe. 2023;5(2):e100-e101. Database Syst Rev. 2015;1(1):CD004875.
doi: 10.1016/S2666-5247(23)00344-0 doi: 10.1002/14651858.CD004875.pub5
7. WHO. Upsurge of Respiratory Illnesses among Children- 17. Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of
Northern China; 2023. Available from: https://www.who.int/ Mycoplasma pneumoniae in the upper respiratory tract of
emergencies/disease-outbreak-news/item/2023-DON494 symptomatic and asymptomatic children: An observational

Volume 1 Issue 1 (2024) 123 doi: 10.36922/mi.3599